Life sciences sector must prioritize talent experience and tech skills development to overcome talent shortage, according to Randstad Sourceright research

2022 Talent Trends research finds two-thirds (67%) of life sciences and pharma companies say reskilling current employees is an effective way to address talent shortages 

ATLANTA, July 12, 2022 /PRNewswire/ -- Randstad Sourceright's 2022 life sciences and pharma Talent Trends report found that a third (33%) of C-suite and human capital leaders in the life sciences and pharmaceuticals sector say talent scarcity is a major pain point for the sector, which is hiring extensively this year. With demand for life sciences products expected to grow faster than the global GDP in the next few years, 45% of those same talent leaders say the main reason they are looking to hire is to prevent talent scarcity from slowing their business.

As a recession-proof business and one of the few sectors which saw its employment base expand during the pandemic, COVID-19 contributed to skyrocketing demand for a broad variety of technology skills in the life sciences. Organizations have seen demand for data scientists grow as they work to bring new innovations to market. At the same time, life sciences businesses are increasingly competing with the IT and communications sector for engineers and other tech skills as they work to develop new vaccine and diagnostic technologies. Many of these companies are refocusing on other areas of development in emerging fields like bioinformatics and medtech, which will require high-demand tech talent to execute.

"The life sciences and pharmaceuticals sector faced tremendous pressure to deliver life-saving innovations during the pandemic, and they rose to the challenge," said Mike Smith, global CEO of Randstad Sourceright. "Now, the need for medical innovation has only grown, forcing organizations to compete across all industries for a limited supply of in-demand tech talent. Failing to win the race for those skills will be costly, but a strong focus on the talent experience; offering purposeful workplace culture; maximizing flexibility; and investing in diversity, equity and inclusion can help companies stand out. Reskilling and upskilling talent will also be essential to combat talent scarcity and demonstrate how much organizations value their people."

The number of open roles for high-skilled talent is rising rapidly, due in large part to the widening skills gap in the life sciences sector. In fact, it takes 105 days on average to fill a non-executive position in the U.S. life sciences sector, resulting in a loss of $500 a day. The growing skills gap threatens further progress, making smart talent strategies essential to setting life sciences and pharma organizations on the path to innovation.

Creating a more diverse and inclusive workforce is one area in need of improvement in the life sciences sector. While 60% say that workplace diversity, equity and inclusion (DEI) efforts are fundamental to attracting, engaging, and retaining talent, just 41% say their hiring practices supported their diversity goals last year, the lowest among all sectors surveyed. At the same time, 63% of life sciences and pharma leaders believe DEI are important to candidates — also the lowest percentage of surveyed sectors.

Another key strategy to help life sciences firms address both the growing skills gap and increased competition for talent involves a commitment to upskilling current employees. "Our research shows that 67% of life sciences and pharma leaders report that reskilling current employees for different roles has been effective in addressing talent shortages," said Smith. "It also has the added benefit of showing employees how much the organization values them. So it's not surprising we see investments in internal mobility platforms growing, with 63% of leaders already investing in these platforms, and 53% saying they will be investing more in this area."

To access the complete data, download a copy of Randstad Sourceright's "2022 Talent Trends: life sciences & pharma" report here.

About the Randstad Sourceright Talent Trends research. 
Our 2022 Talent Trends research, includes the views of more than 900 human capital and C-suite leaders in 18 markets. The full report can be accessed here.

About Randstad Sourceright.
Randstad Sourceright is a global talent solutions leader, driving the talent acquisition and human capital management strategies for the world's most successful employers. We empower companies by leveraging a Human Forward strategy that balances the use of innovative technologies with expert insights, supporting both organizations and people in realizing their true potential.  

As an operating company of Randstad N.V. — the world's leading global provider of HR services with revenue of € 20.7 billion — Randstad Sourceright's subject matter experts and thought leaders around the world continuously build and evolve our solutions across recruitment process outsourcing (RPO), managed services programs (MSP) and total talent solutions.

Read more at  randstadsourceright.com.

SOURCE Randstad Sourceright